Dr. Lai Wang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Lai Wang
BeOne Medicines Ltd. reported in an 8-K filed December 18, 2025 that Dr. Lai Wang was appointed President, Global Head of Research and Development, effective December 17, 2025.
“On December 17, 2025, BeOne Medicines Ltd. (the “Company”) appointed Dr. Lai Wang to serve as President, Global Head of Research and Development of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BeOne Medicines Ltd. (ONC)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BeOne Medicines Ltd.
Other people whose current roles at this company are on record from its filings.
- Mr. John V. Oyler CEO, Board Member
- John V. Oyler Chairman
- Mr. Aaron Rosenberg CFO
- Dr. Xiaobin Wu COO
- Mr. Chan Lee General Counsel
- Titus Ball Chief Accounting Officer
- Alessandro Riva, M.D. Board Member
- Charles L. Sawyers Board Member
- Corazon (Corsee) D. Sanders Board Member
- Corsee Sanders, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.